New Blood Test May Improve Diagnosis and Prognosis of Acute Spinal-Cord Injury
Dato Capt. Mahesan Subramaniam, Co-Founder of United Health Tourism, posted on LinkedIn:
“New blood test may improve diagnosis and prognosis of acute spinal-cord injury.
Researchers have developed a blood test that can detect damage to the spinal cord almost immediately after injury, helping doctors assess severity and predict recovery. The test measures fragments of spinal-cord cell DNA released into the bloodstream, along with key proteins linked to nerve damage. Higher levels of these markers have been shown to correlate with more severe injuries and worse outcomes months later.
In addition to these novel markers, another study found that ordinary blood tests already used in hospitals—tracking things like immune cell counts, electrolytes, and metabolic indicators—can be analyzed over time using machine-learning tools to predict whether a patient has serious spinal-cord damage, will survive, or how well they might recover. These predictions become more accurate as more data accumulate in the first days after injury.
If validated further and adopted widely, these developments might shift spinal-cord injury care from reactive to proactive. By giving clinicians objective data early on, treatment plans and resource allocation can be better tailored to each patient’s risk. Ultimately, patients might benefit from more individualized treatment and improved outcomes based on timely biological insights.”
Find more posts featuring Dato Capt. Mahesan Subramaniam on Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin